Skip to main content
. 2017 Mar 25;2017(3):CD010931. doi: 10.1002/14651858.CD010931.pub2

Comparison 36. Exposure to clomiphene; comparison group: general population; any; follow‐up>10 years.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Endometrial cancer; subgroup by effect estimate 3 18931 Risk Ratio (Random, 95% CI) 2.08 [1.01, 4.28]
1.1 SIR 2 4106 Risk Ratio (Random, 95% CI) 1.61 [0.79, 3.29]
1.2 HR 1 14825 Risk Ratio (Random, 95% CI) 4.56 [1.56, 13.33]